CZ290298A3 - Farmaceutický prostředek proti bipolárních poruše - Google Patents

Farmaceutický prostředek proti bipolárních poruše Download PDF

Info

Publication number
CZ290298A3
CZ290298A3 CZ982902A CZ290298A CZ290298A3 CZ 290298 A3 CZ290298 A3 CZ 290298A3 CZ 982902 A CZ982902 A CZ 982902A CZ 290298 A CZ290298 A CZ 290298A CZ 290298 A3 CZ290298 A3 CZ 290298A3
Authority
CZ
Czechia
Prior art keywords
bipolar disorder
olanzapine
treatment
bipolar
disorder
Prior art date
Application number
CZ982902A
Other languages
Czech (cs)
English (en)
Inventor
Charles Merritt Beasley Jr.
Gary Dennis Tollefson
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CZ290298A3 publication Critical patent/CZ290298A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
CZ982902A 1996-03-11 1996-12-04 Farmaceutický prostředek proti bipolárních poruše CZ290298A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11

Publications (1)

Publication Number Publication Date
CZ290298A3 true CZ290298A3 (cs) 1999-10-13

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ982902A CZ290298A3 (cs) 1996-03-11 1996-12-04 Farmaceutický prostředek proti bipolárních poruše

Country Status (15)

Country Link
EP (1) EP0889725A4 (xx)
JP (1) JP2000506859A (xx)
KR (1) KR19990087713A (xx)
CN (1) CN1213966A (xx)
AU (1) AU734011B2 (xx)
BR (1) BR9612548A (xx)
CZ (1) CZ290298A3 (xx)
EA (1) EA000758B1 (xx)
HU (1) HUP9903679A3 (xx)
IL (1) IL126162A0 (xx)
NO (1) NO984189D0 (xx)
NZ (1) NZ326031A (xx)
PL (1) PL328925A1 (xx)
TR (1) TR199801797T2 (xx)
WO (1) WO1997033577A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002516282A (ja) * 1998-05-22 2002-06-04 イーライ・リリー・アンド・カンパニー 難治性鬱病の処置のための組合せ治療
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
EP0966967A3 (en) * 1998-05-29 2000-05-31 Eli Lilly And Company Combination therapy of olanzapine (zyprexa) and fluoxetine (prozac) for treatment of bipolar disorder
JP2002530341A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． デスメチルオランザピン組成物及び方法
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
JP2002530340A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． オランザピン−ｎ−オキサイドを含む医薬組成物
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
EA199800819A1 (ru) 1999-02-25
IL126162A0 (en) 1999-05-09
EP0889725A4 (en) 2000-01-19
TR199801797T2 (xx) 1998-12-21
NO984189L (no) 1998-09-11
PL328925A1 (en) 1999-03-01
WO1997033577A1 (en) 1997-09-18
NZ326031A (en) 2001-05-25
HUP9903679A2 (hu) 2000-04-28
JP2000506859A (ja) 2000-06-06
NO984189D0 (no) 1998-09-11
KR19990087713A (ko) 1999-12-27
EP0889725A1 (en) 1999-01-13
CN1213966A (zh) 1999-04-14
BR9612548A (pt) 1999-07-20
AU734011B2 (en) 2001-05-31
HUP9903679A3 (en) 2001-10-29
AU1330797A (en) 1997-10-01
EA000758B1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
CZ290298A3 (cs) Farmaceutický prostředek proti bipolárních poruše
AU709181B2 (en) Method for treating autism
US5744470A (en) Method for treating insomnia
EP0900085B1 (en) Treatment of excessive aggression with olanzapine
US6274636B1 (en) Method for treating a tic disorder
US6071902A (en) Method for treating excessive aggression
AU724245B2 (en) Method for treating insomnia
CA2248905A1 (en) Method for treating bipolar disorder
GB2305860A (en) Anti-emetic
MXPA98007431A (en) Medications to treat the bipo disorder
MXPA98007438A (en) Medications to treat the insom
GB2305859A (en) Treatment of obsessive-compulsive disorder

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic